Kraig Biocraft Laboratories, Inc. (KBLB) Form 10-Q — May 14, 2026
Kraig Biocraft Laboratories reported a net loss of $942,720 for the three months ended March 31, 2026, with zero revenue generated. The company ended the quarter with $2.89 million in cash but faces a working capital deficit of $7.67 million and total liabilities exceeding $10.7 million. The filing includes a going-concern warning, stating that net losses and capital deficiency raise substantial doubt about the company's ability to continue as a going concern. Management acknowledged that cash resources are insufficient to meet planned business objectives without additional financing.
Key figures
- Revenue
- 0
- Total Debt
- 10783506
- Total Assets
- 3721832
- Cash Position
- 2890990
- Shares Outstanding
- 1113049449
- Sepa Proceeds Q1
- 1644588
- Gold Bullion Value
- 514667
- Sepa Total Capacity
- 10000000
Price after filing
Close on the filing date to close N calendar days later (from $0.14). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.